| Product Code: ETC6503122 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Brazil continued to heavily rely on imports of daptomycin, with major exporting countries including China, Italy, South Korea, USA, and Taiwan. The High Herfindahl-Hirschman Index (HHI) indicates a concentrated market, suggesting potential challenges in terms of competition and market dynamics. Despite a healthy Compound Annual Growth Rate (CAGR) of 6.7% from 2020 to 2024, a slight decline in the growth rate from 2023 to 2024 at -6.06% raises questions about the future trajectory of daptomycin imports in Brazil. Monitoring market trends and factors influencing growth will be crucial for stakeholders in the pharmaceutical industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brazil Daptomycin Market Overview |
3.1 Brazil Country Macro Economic Indicators |
3.2 Brazil Daptomycin Market Revenues & Volume, 2021 & 2031F |
3.3 Brazil Daptomycin Market - Industry Life Cycle |
3.4 Brazil Daptomycin Market - Porter's Five Forces |
3.5 Brazil Daptomycin Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Brazil Daptomycin Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.7 Brazil Daptomycin Market Revenues & Volume Share, By Strength, 2021 & 2031F |
3.8 Brazil Daptomycin Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Brazil Daptomycin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Brazil |
4.2.2 Growing awareness and adoption of advanced antibiotics like daptomycin |
4.2.3 Rising healthcare expenditure and focus on improving healthcare infrastructure in Brazil |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Brazil |
4.3.2 High cost associated with daptomycin treatment |
4.3.3 Competition from alternative antibiotics and generic drugs |
5 Brazil Daptomycin Market Trends |
6 Brazil Daptomycin Market, By Types |
6.1 Brazil Daptomycin Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Brazil Daptomycin Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Brazil Daptomycin Market Revenues & Volume, By Complicated Skin Structure Infections, 2021- 2031F |
6.1.4 Brazil Daptomycin Market Revenues & Volume, By Bacteremia, 2021- 2031F |
6.1.5 Brazil Daptomycin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Brazil Daptomycin Market, By Age Group |
6.2.1 Overview and Analysis |
6.2.2 Brazil Daptomycin Market Revenues & Volume, By Paediatric, 2021- 2031F |
6.2.3 Brazil Daptomycin Market Revenues & Volume, By Adult, 2021- 2031F |
6.3 Brazil Daptomycin Market, By Strength |
6.3.1 Overview and Analysis |
6.3.2 Brazil Daptomycin Market Revenues & Volume, By 350mg, 2021- 2031F |
6.3.3 Brazil Daptomycin Market Revenues & Volume, By 500mg, 2021- 2031F |
6.4 Brazil Daptomycin Market, By End-User |
6.4.1 Overview and Analysis |
6.4.2 Brazil Daptomycin Market Revenues & Volume, By Pharmaceuticals, 2021- 2031F |
6.4.3 Brazil Daptomycin Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Brazil Daptomycin Market Revenues & Volume, By Wellness Centers, 2021- 2031F |
7 Brazil Daptomycin Market Import-Export Trade Statistics |
7.1 Brazil Daptomycin Market Export to Major Countries |
7.2 Brazil Daptomycin Market Imports from Major Countries |
8 Brazil Daptomycin Market Key Performance Indicators |
8.1 Number of reported cases of bacterial infections in Brazil |
8.2 Percentage increase in prescriptions of daptomycin |
8.3 Investment in healthcare infrastructure and facilities in Brazil |
8.4 Research and development expenditure on new antibiotic technologies |
8.5 Patient adherence and compliance rates with daptomycin treatment |
9 Brazil Daptomycin Market - Opportunity Assessment |
9.1 Brazil Daptomycin Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Brazil Daptomycin Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.3 Brazil Daptomycin Market Opportunity Assessment, By Strength, 2021 & 2031F |
9.4 Brazil Daptomycin Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Brazil Daptomycin Market - Competitive Landscape |
10.1 Brazil Daptomycin Market Revenue Share, By Companies, 2024 |
10.2 Brazil Daptomycin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |